BRAIN RELAPSE IN HER2-POSITIVE BREAST CANCER AFTER NEOADJUVANT TREATMENT: AN INTERNATIONAL MULTICENTRIC STUDY

被引：1

作者：

Fortuna, A. ^{[1
]}

Nobre Carvalho, A. ^{[2
]}

Soares de Pinho, I. ^{[3
]}

Lopes-Bras, R. ^{[3
]}

Patel, V. ^{[3
]}

Esperanca-Martins, M. ^{[3
]}

Goncalves, L. ^{[3
]}

Freitas, R. ^{[4
]}

Simao, D. ^{[5
]}

Roldan Galnares, M. ^{[6
]}

Fernandes, I. ^{[7
]}

Artacho Criado, S. ^{[6
]}

Gamez Casado, S. ^{[8
]}

Baena Canada, J. ^{[8
]}

Saffie Vega, I. M. ^{[9
]}

Costa, J. ^{[10
]}

Fernandes, A. S. ^{[10
]}

Teixeira de Sousa, R. ^{[3
]}

Costa, L. ^{[3
]}

Luz, P. ^{[1
,10
,11
]}

机构：

[1] Ctr Hosp Univ Algarve, Faro, Portugal

[2] Ctr Hosp Entre Douro e Vouga, Med Oncol, EPE, Santa Maria, RS, Portugal

[3] Hosp Santa Maria, CHULN, Med Oncol Dept, Lisbon, Portugal

[4] Hosp Prof Dr Fernando Fonseca, Med Oncol Dept, Amadora, Portugal

[5] Ctr Hosp Lisboa Cent, Med Oncol Dept, Lisbon, Portugal

[6] Hosp Virgen de Valme, Pharma Dept, Seville, Spain

[7] Ctr Hosp Barreiro Montijo, Med Oncol Dept, Barreiro, Portugal

[8] Hosp Univ Puerta del Mar, Med Oncol Dept, Cadiz, Spain

[9] Fdn Arturo Lopez Perez, Unidad Cirugia Oncol & Reconstructiva Mamaria, Providencia, Chile

[10] CBIOS Univ Lusofonas Res Ctr Biosci & Hlth Techno, Lisbon, Portugal

[11] Univ Alcala, Dept Biomed Sci, Madrid, Spain

来源：

NEURO-ONCOLOGY | 2023年 / 25卷

关键词：

D O I：

10.1093/neuonc/noad137.288

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P11.54.A

引用

页数：1

共 50 条

[21] LAPATINIB AND CAPECITABINE IN THE TREATMENT OF HER2-POSITIVE BREAST CANCER WITH BRAIN METASTASES
Dubianski, R.
Brewczynska, E.
Lemanska, I.
Szombara, E.
Nowecki, Z. I.
ANNALS OF ONCOLOGY, 2014, 25
[22] Review of the status of neoadjuvant therapy in HER2-positive breast cancer
Dowling, Gavin P.
Keelan, Stephen
Toomey, Sinead
Daly, Gordon R.
Hennessy, Bryan T.
Hill, Arnold D. K.
FRONTIERS IN ONCOLOGY, 2023, 13
[23] Progression and treatment of HER2-positive breast cancer
April Davoli
Barbara A. Hocevar
Thomas L. Brown
Cancer Chemotherapy and Pharmacology, 2010, 65 : 611 - 623
[24] Optimizing Treatment of HER2-Positive Breast Cancer
Gradishar, William J.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2015, 13 (5.5): : 649 - 651
[25] Adjuvant treatment for HER2-positive breast cancer
Burki, Talha Khan
LANCET ONCOLOGY, 2015, 16 (02): : E59 - E59
[26] Neoadjuvant pertuzumab in non-metastatic HER2-positive breast tumors: Multicentric study in Peru (NeoHer)
Falcon, Silvia
Riva, Luis
Flores, Christina
Vera, Delphis
Pinto, Joseph A.
Gomez, Henry L.
MOLECULAR AND CLINICAL ONCOLOGY, 2022, 16 (03)
[27] Treatment Combinations for HER2-Positive Breast Cancer
Pegram, Mark
ONCOLOGY-NEW YORK, 2013, 27 (04): : 258 - +
[28] Treatment strategy for HER2-positive breast cancer
Mukai, Hirofumi
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2010, 15 (04) : 335 - 340
[29] Preoperative treatment of HER2-positive breast cancer
Wysocki, Piotr J.
Krzakowski, Maciej
ONCOLOGY IN CLINICAL PRACTICE, 2020, 16 (02): : 69 - 74
[30] The Adjuvant Treatment of HER2-Positive Breast Cancer
Danijela Jelovac
Antonio C. Wolff
Current Treatment Options in Oncology, 2012, 13 : 230 - 239

← 1 2 3 4 5 →